BioCardia Performance
The firm shows a Beta (market volatility) of 0.56, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, BioCardia's returns are expected to increase less than the market. However, during the bear market, the loss of holding BioCardia is expected to be smaller as well. BioCardia right now shows a risk of 0.0%. Please confirm BioCardia coefficient of variation, treynor ratio, as well as the relationship between the Treynor Ratio and semi variance , to decide if BioCardia will be following its price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days BioCardia has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, BioCardia is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors. ...more
| Begin Period Cash Flow | 7.4 M | |
| Free Cash Flow | -10 M |
BioCardia |
BioCardia Relative Risk vs. Return Landscape
If you would invest (100.00) in BioCardia on August 29, 2024 and sell it today you would earn a total of 100.00 from holding BioCardia or generate -100.0% return on investment over 90 days. BioCardia is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded stocks are less volatile than BioCardia, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
BioCardia Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for BioCardia's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as BioCardia, and traders can use it to determine the average amount a BioCardia's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| BCDAW |
Based on monthly moving average BioCardia is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of BioCardia by adding BioCardia to a well-diversified portfolio.
BioCardia Fundamentals Growth
BioCardia Stock prices reflect investors' perceptions of the future prospects and financial health of BioCardia, and BioCardia fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on BioCardia Stock performance.
| Return On Equity | -7.04 | |||
| Return On Asset | -1.33 | |||
| Operating Margin | (41.36) % | |||
| Revenue | 477 K | |||
| EBITDA | (11.23 M) | |||
| Total Debt | 1.31 M | |||
| Book Value Per Share | (1.27) X | |||
| Cash Flow From Operations | (9.97 M) | |||
| Earnings Per Share | (3.20) X | |||
| Total Asset | 2.99 M | |||
| Retained Earnings | (152.18 M) | |||
About BioCardia Performance
Evaluating BioCardia's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if BioCardia has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if BioCardia has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Things to note about BioCardia performance evaluation
Checking the ongoing alerts about BioCardia for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for BioCardia help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| BioCardia is not yet fully synchronised with the market data | |
| BioCardia has some characteristics of a very speculative penny stock | |
| BioCardia has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 477 K. Net Loss for the year was (11.57 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| BioCardia generates negative cash flow from operations |
- Analyzing BioCardia's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether BioCardia's stock is overvalued or undervalued compared to its peers.
- Examining BioCardia's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating BioCardia's management team can have a significant impact on its success or failure. Reviewing the track record and experience of BioCardia's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of BioCardia's stock. These opinions can provide insight into BioCardia's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Consideration for investing in BioCardia Stock
If you are still planning to invest in BioCardia check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BioCardia's history and understand the potential risks before investing.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |